CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 53 enrolled
Drug / intervention
Placebo +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03609853
NCT03609853Phase 1Completed
CompareCT.gov

Behavioral Pharmacology of THC and D-limonene

Johns Hopkins University·interventional·Posted Aug 1, 2018·Updated Dec 11, 2023

In Brief

A Phase 1 clinical trial evaluating Placebo and Vaporized THC, limonene, or THC and limonene for D-limonene and THC Pharmacodynamics. Completed, enrolled 53 participants across 1 site.

Detailed Summary

This study will evaluate the pharmacokinetics and pharmacodynamics of vaporized d-limonene and THC administered via inhalation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsD-limonene and THC Pharmacodynamics
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA)

Timeline

Phase 1CompletedFinished
20192020202120222023202420252026
First PostedAug 1, 2018
Enrollment StartApr 1, 2019
Primary CompletionJun 28, 2022
Study CompletionOct 25, 2023
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 7.9 years ago

Interventions

Placebodrug

Placebo vapor (distilled water)

Vaporized THC, limonene, or THC and limonenedrug

Acute drug exposure